Desert King International LLC
- Type: Wholesaler & Distributor
- Location: Chula Vista, California
USDA certified organic operation (certified by Oregon Tilth Certified Organic), certified for handling. Certified products include: Inca Gold (Golden Jojoba Oil), Inca Lite DEO, Magni- Phi, Magni- Phi L, Magni- Phi Ultra, Nutrafito Plus (Quillaja & Yucca blend), QDP Ultra, Andean Q Ultra, Q Ultra, QL Ultra, Q-Naturale 300 Emulsifier, Quillaja Ultra.
News and blog (10)
- Regional Pride: Desert King's global leadership in quillaja extracts: At Desert King, we are proud to bring the best of Chilean nature to the global stage. Through SOFOFA's “Orgullo Regional” (Regional Pride) campaign, we…
- Wei, L., et al. Saponin derivative and MPLA-adjuvanted intranasal protein nanoparticle vaccines induce potent mucosal immunity and durable heterologous influenza protection in mice: Nanomedicine, 2026 Aug 19:103008. PMID: 42617671 The authors introduce a novel intranasal protein nanoparticle influenza vaccine formulated with a…
- Lu, J., et al. Lysosomal disruption elicits immunogenic cell death: A saponin-nanoaluminum adjuvant for enhanced cancer immunotherapy: Acta Biomater, 2026 Aug, 220:276-291. PMID: 42468600 This paper introduces a novel saponin-based nanoadjuvant, QS-NanoAlum, that leverages lysosomal…
- Eckhardt, E., et al. Comparison of the adjuvant effect of AS01, AS03 and alum on the immune response to GMP-grade H5N1 antigen in guinea pigs: Sci Rep, 2026 Aug 20, 16(1):26175. PMID: 42624960 Read this comprehensive comparison of the adjuvant effects of two advanced formulations, AS01 (containing…
- Steichen, J.M., et al. Vaccination elicits HIV broadly neutralizing antibodies in primates: Nature, 2026 Aug, 656(8128):723-733. PMID: 42380658 Building upon the design of germline-targeted Env immunogens that effectively prime V2 apex bnAb…
- Marchitto, L., et al. Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies: Nature, 2026 Aug, 656(8128):712-722. PMID: 42380659 This Nature paper presents a significant advance in HIV vaccine design by demonstrating that…
- Tregunno, C., et al. AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (Adjuvanted RSVPreF3): Review of the First 2 Years of Post-Marketing Safety Surveillance: Drug Saf, 2026 Aug 1. PMID: 42541670 Are you interested in a comprehensive two-year post-marketing safety surveillance of the AS01E-adjuvanted RSVPreF3…
- Zhang, Y., et al. CD25+ cell depletion enhances protective immunity of PR8 inactivated influenza vaccine in aged mice. Virology, 2026 Aug, 621:110938. PMID: 42107283: This paper highlights the synergistic potential of combining saponin-based ISCOM adjuvants with immune regulatory modulation, specifically transient depletion…
- Pyles, K., et al. Intranasal and intramuscular H5-Matrix-M nanoparticle vaccines protects against highly pathogenic H5N1 influenza virus in mice. NPJ Vaccines, 2026 Jul 10. PMID: 42431930: This study evaluates the immunogenicity and protective efficacy of a recombinant H5 hemagglutinin (HA) nanoparticle vaccine adjuvanted with Matrix-M…
- Haupt, S., et al. Rapid boosting increases germinal center responses to sequential vaccines. Nat Immunol, 2026 Jul, 27(7):1476-1489. PMID: 42337116: This paper explores how rapid boosting strategies can significantly enhance germinal center (GC) responses in the context of HIV vaccination, particularly…